
Tech • IA • Crypto
A French entrepreneur with a neurodegenerative disease is using AI to restore his voice and push for faster medical innovation, while challenging Silicon Valley’s vision of defeating death.
After losing his natural speech due to illness, Olivier used AI to reconstruct his original voice from past recordings. The first thing he did was leave a joking voicemail for his mother, who recognized her son rather than a synthetic substitute. This breakthrough illustrates how generative AI can preserve identity and human connection, not just functionality.
Formerly a fintech entrepreneur, Olivier has shifted his focus toward building bridges between research, art, and technology. His work now centers on accelerating progress in neurodegenerative diseases, using his experience in startups to mobilize funding, partnerships, and public attention.
His flagship initiative, Invincible Hope, is a large-scale public artwork planned for Mount Sinai Hospital in New York. The installation will feature thousands of portraits forming a monumental message, visible for months. Each sponsored segment raises funds—starting at $50,000 per letter—toward a $500,000 goal to support AI-driven research collaborations between the U.S. and France.
Unlike traditional voice synthesis tools, Olivier’s system, Invincible Voice, functions as a conversational AI. It analyzes context, suggests responses based on his thinking style, and speaks in his reconstructed voice. This allows real-time dialogue rather than slow, letter-by-letter communication, marking a shift from static tools to dynamic interaction.
The arrival of ChatGPT in 2022 marked a decisive moment. As Olivier lost motor and vocal abilities, generative AI became an interface between his thoughts and the outside world. He argues this technology represents a major leap for people with disabilities, transforming communication from mechanical to expressive.
Olivier contrasts his experience with Silicon Valley’s dual obsession: optimizing the body and escaping it. While some pursue longevity or digital consciousness, he emphasizes staying human within physical limits. He argues that treating death as a failure risks stripping life of meaning.
Facing a terminal diagnosis reframed his priorities. Rather than paralysis, the awareness of death brought clarity and urgency. Every interaction gained weight, echoing the idea of “memento mori” as a call to live fully rather than avoid mortality.
He criticizes delays in public health decisions, citing a drug approved in the U.S. in 2023 and Europe in 2024, yet still pending reimbursement in France. Such delays, he argues, cost lives and reflect a mismatch between urgency and bureaucracy.
Neurodegenerative diseases affect 1 in 3 people and cost Europe around €1 trillion annually, yet remain underfunded. Olivier calls for prioritizing brain diseases at the same level as climate change, urging both governments and tech leaders to act.
The Cure ALS alliance brings together institutes from France, Germany, the UK, and Belgium, involving over 2,500 researchers. By sharing data and coordinating clinical trials, the initiative aims to overcome fragmentation that has slowed progress for decades.
His Invincible Summer fund is structured to last nearly a century, with investors accepting capped returns so excess profits fund research continuously. A €20 million fund could generate around €1 million annually for science, creating a long-term financing model beyond traditional donations.
Olivier urges figures like Sam Altman, Elon Musk, and Dario Amodei to dedicate resources to brain research. With 57 million people affected today and 152 million projected by 2050, he frames it as the most complex and urgent frontier for AI.
By combining AI innovation with advocacy and long-term funding models, Olivier is redefining how technology can preserve human dignity while accelerating the fight against neurodegenerative diseases.